GlassScriptPhysician profile
Justine Summers
NPI 1851776447
$4,498.43
in general payments reported to CMS, 2019-2025
33 companies · $1,591 in 2025
The $1,591 reported for 2025 was more than what 93% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $850 · 2022: $68.48 · 2023: $978 · 2024: $1,011 · 2025: $1,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,500 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,500.13 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $690.52 | 2023-2025 | Fasenra, Airsupra |
| Atricure, INC. | $534.62 | 2021 | |
| Glaxosmithkline, LLC. | $524.24 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Regeneron Healthcare Solutions, INC. | $355.98 | 2022-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.04 | 2022-2025 | Ofev, Jardiance |
| Abiomed | $217.38 | 2021 | |
| Pfizer INC. | $173.24 | 2025 | |
| United Therapeutics Corporation | $168.15 | 2023-2024 | Tyvaso |
| Novo Nordisk INC | $156.25 | 2025 | Wegovy, Rybelsus, Ozempic |
| Insmed, INC. | $134.88 | 2024 | Arikayce |
| Inogen, INC. | $134.30 | 2024 | |
| Mylan Specialty L.P. | $110.43 | 2023-2024 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $106.52 | 2025 | Rexulti |
| La Jolla Pharmaceutical Company | $97.88 | 2021 | |
| Viiv Healthcare Company | $82.69 | 2025 | Apretude |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $70.98 | 2025 | |
| Astellas Pharma US INC | $61.33 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $60.09 | 2025 | Gardasil 9, Capvaxive, Rotateq |
| Lilly USA, LLC | $59.88 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $54.61 | 2024-2025 | Repatha, Otezla, Tezspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.08 | 2025 | Caplyta |
| Abbvie INC. | $48.15 | 2025 | |
| Boston Scientific Corporation | $43.69 | 2023-2024 | Bodyguardian |
| Baxter Healthcare | $37.15 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Vertex Pharmaceuticals Incorporated | $32.68 | 2025 | |
| Axsome Therapeutics, INC. | $30.26 | 2025 | Symbravo, Auvelity |
| Alkermes, INC. | $24.86 | 2025 | Vivitrol |
| Cranial Technologies, INC | $19.68 | 2025 | Doc Band |
| Novartis Pharmaceuticals Corporation | $19.12 | 2025 | |
| Organon LLC | $16.85 | 2025 | Nexplanon |
| Aimmune Therapeutics, INC. | $16.76 | 2025 | Zenpep |
| Corcept Therapeutics | $14.27 | 2025 | Korlym |
| Medtronic, INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justine Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.